Abstract
Photoimmunology is the study of the effects of non-ionizing electromagnetic radiation (principally ultraviolet light) on the immune system. Ultraviolet (UV) light represents the spectrum of electromagnetic radiation between the wavelengths of 100 and 400 nm. Through its actions on the immune system, UV radiation promotes the development of skin cancers, modulates the development of allergic contact dermatitis, and triggers several specific photosensitivity disorders collectively known as the immunologically-mediated photodermatoses. These disorders include polymorphic light eruption, actinic prurigo, solar urticaria, hydro vacciniforme, and chronic actinic dermatitis. In addition to discussing the molecular underpinnings of UV-induced carcinogenesis and the effects of UV radiation on contact hypersensitivy responses, this chapter reviews the clinical features, epidemiology, pathophysiology and treatment of the immunologically-mediated photodermatoses. Additionally, this chapter highlights the key immunologic mechanisms by which UV radiation is used therapeutically to treat dermatologic diseases, especially T-cell mediated skin disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wondrak GT, Jacobson MK, Jacobson EL. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci. 2006;5(2):215–37.
Berneburg M, Krutmann J. Photoimmunology, DNA repair and photocarcinogenesis. J Photochem Photobiol B. 2000;54(2–3):87–93.
Black HS, et al. Photocarcinogenesis: an overview. J Photochem Photobiol B. 1997;40(1):29–47.
Sarasin A. The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res. 1999;428(1–2):5–10.
Urbach F, Forbes PD, Davies RE, Berger D. Cutaneous photobiology: past, present and future. J Invest Dermatol. 1976;67(1):209–24.
de Gruijl FR, et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 1993;53(1):53–60.
Sterenborg HJ, van der Leun JC. Tumorigenesis by a long wavelength UV-A source. Photochem Photobiol. 1990;51(3):325–30.
Longstreth J. Cutaneous malignant melanoma and ultraviolet radiation: a review. Cancer Metastasis Rev. 1988;7(4):321–33.
Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63(1–3):8–18.
Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(30):3099–112.
Wang SQ, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol. 2001;44(5):837–46.
Noonan FP, et al. Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Nat Commun. 2012;3:884.
Hart RW, Setlow RB, Woodhead AD. Evidence that pyrimidine dimers in DNA can give rise to tumors. Proc Natl Acad Sci U S A. 1977;74(12):5574–8.
Schwarz A, et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol. 2004;172(2):1036–43.
Elmets CA, et al. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med. 1983;158(3):781–94.
Matthews YJ, Halliday GM, Phan TA, Damian DL. Wavelength dependency for UVA-induced suppression of recall immunity in humans. J Dermatol Sci. 2010;59(3):192–7.
Halliday GM, et al. The suppression of immunity by ultraviolet radiation: UVA, nitric oxide and DNA damage. Photochem Photobiol Sci. 2004;3:736–40.
Vermeer M, Streilein JW. Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed. 1990;7(6):258–65.
Yoshikawa T, Kurimoto I, Streilein JW. Tumour necrosis factor-alpha mediates ultraviolet light B enhanced expression of contact hypersensitivity. Immunology. 1992;76(2):264–71.
Simon JC, Cruz PD, Bergstresser PR, Tigelaar RE. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset. J Immunol. 1990;145:2087–91.
Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol. 1998;160(8):3783–9.
Walterscheid JP, Ullrich SE, Nghiem DX. Platelet activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med. 2002;195(2):171–9.
Marathe GK, et al. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J Biol Chem. 2005;280(42):35228–457.
Moodycliffe AM, Kimber I, Norval M. The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology. 1992;77(3):394–9.
El-Ghorr AA, Norval M. A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in Langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J Invest Dermatol. 1995;105(2):264–8.
Walterscheid JP, et al. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci U S A. 2006;103(46):17420–5.
Niizeki H, Alard P, Streilein JW. Calcitonin gene-related peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity. J Immunol. 1997;159:5183–6.
Shreedhar VK, et al. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol. 1998;161(3):1327–35.
Aberer W, et al. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol. 1981;76(3):202–10.
Glass MJ, Bergstresser PR, Tigelaar RE, Streilein JW. UVB radiation and DNFB skin painting induce suppressor cells universally in mice. J Invest Dermatol. 1990;94(3):273–8.
Schwarz T, Beissert S. Milestones in photoimmunology. J Invest Dermatol. 2013;133(E1):E7–10.
Stein P, et al. UV exposure boosts transcutaneous immunization and improves tumor immunity: cytotoxic T-cell priming through the skin. J Invest Dermatol. 2011;131:211–9.
Fukunaga A, et al. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J Immunol. 2008;180:3057–64.
Yoshiki R, et al. The mandatory role of IL-10 producing and OX40 ligand-expressing mature Langerhans cells in UVB-induced immunosuppression. J Immunol. 2010;184:5670–7.
Aragane Y, et al. Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J Immunol. 2003;171(7):3801–7.
Schwarz T. Regulatory T cells induced by ultraviolet radiation. Int Arch Allergy Immunol. 2005;137(3):187–93.
Fukunaga A, et al. Langerhans cells serve as immunoregulatory cells by activating NKT cells. J Immunol. 2010;185(8):4633–40.
Li Y-H, et al. Protective effects of green tea extracts on photoaging and photoimmunosuppression. Skin Res Tech. 2009;15:338–45.
Hart PH, et al. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med. 1998;187(12):2045–53.
Rauterberg A, Jung EG, Rauterberg EW. Complement deposits in epidermal cells after ultraviolet B exposure. Photodermatol Photoimmunol Photomed. 1993;9(4):135–43.
Hammerberg C, Katiyar SK, Carroll MC, Cooper KD. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J Exp Med. 1998;187(7):1133–8.
Yoshida Y, et al. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol. 1998;161(11):5873–9.
Ullrich SE, Byrne SN. The immunologic revolution: photoimmunology. J Invest Dermatol. 2012;132:896–905.
Byrne SN, Sarchio SN. AMD3100 protects from UV-induced skin cancer. Oncoimmunology. 2014;3(1–3), e27562.
Sarchio SN, et al. Pharmacologically antagonizing the CXCR4-CXCL12 Chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer. J Invest Dermatol. 2013;134:1091–100.
Grimbaldeston MA, et al. Susceptibility to basal cell carcinoma is associated with high dermal mast cell prevalence in non-sun-exposed skin for an Australian population. Photochem Photobiol. 2003;78(6):633–9.
Grimbaldeston MA, et al. Association between melanoma and dermal mast cell prevalence in sun-unexposed skin. Br J Dermatol. 2004;150:895–903.
Byrne SN, Halliday GM. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J Invest Dermatol. 2005;124:570–8.
Matsumura Y, et al. A role for inflammatory mediators in the induction of immunoregulatory B cells. J Immunol. 2006;177(7):4810–7.
Ponsonby A-L, Lucas RM, van der Mei IAF. UVR, vitamin D and three autoimmune diseases – multiple sclerosis, type I diabetes, rheumatoid arthritis. Photochem Photobiol. 2005;81(6):1267–75.
Breuer J, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75(5):739–58.
Tang JY, et al. Vitamin D in cutaneous carcinogenesis. J Am Acad Dermatol. 2012;67(5):817–26.
Liu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3.
Tokuda N, Levy RB. 1,25-dihydroxyvitamin D3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes. Proc Soc Exp Biol Med. 1996;211:244–50.
Mathieu C, et al. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol. 2004;89–90:449–52.
Ferguson J. Diagnosis and treatment of the common idiopathic photodermatoses. Australas J Dermatol. 2003;44(2):90–6.
Ros AM, Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatol. 1986;3(5):298–302.
Chantorn R, Lim HW, Shwader TA. Photosensitivity disorders in children: part I. J Am Acad Dermatol. 2012;67(6):1093–110.
Tutrone WD, Spann CT, Scheinfeld N, DeLeo VA. Polymorphic light eruption. Dermatol Ther. 2003;16(1):28–39.
Boonstra HE, van Weelden H, Toonstra J, van Vloten WA. Polymorphous light eruption: a clinical, photobiologic, and follow-up study of 110 patients. J Am Acad Dermatol. 2000;42(2 pt 1):199–207.
Lava SA, et al. Juvenile spring eruption: an outbreak report and systematic review of the literature. Br J Dermatol. 2013;168:1066–72.
Lecha M. Idiopathic photodermatoses: clinical, diagnostic and therapeutic aspects. J Eur Acad Dermatol Venereol. 2001;15(6):499–504.
Norris PG, et al. Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol. 1989;120(2):173–83.
Kolgen W, et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol. 1999;113(1):4–10.
Wackernagel A, et al. Langerhans cell resistance, CD11b+ cell influx, and cytokine mRNA expression in skin after UV exposure in patients with polymorphous light eruption as compared with healthy control subjects. J Invest Dermatol. 2004;122(5):1342–4.
Kolgen W, et al. Differential expression of cytokines in UV-B-exposed skin of patients with polymorphous light eruption: correlation with Langerhans cell migration and immunosuppression. Arch Dermatol. 2004;140(3):295–302.
Gambichler T, et al. T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge. Br J Dermatol. 2013;169:1288–94.
Ross G, Foley P, Baker C. Actinic prurigo. Photodermatol Photoimmunol Photomed. 2008;24(5):272–5.
Grabczynska SA, et al. Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR/DRB1*0407. Br J Dermatol. 1999;140(2):232–6.
Sheridan DP, et al. HLA typing in actinic prurigo. J Am Acad Dermatol. 1990;22(6 Pt 1):1019–23.
Dawe RS, Collins P, Ferguson J, O’Sullivan A. Actinic prurigo and HLA-DR4. J Invest Dermatol. 1997;108:233–4.
Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol. 2002;43:128–32.
Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol. 2008;59:909–20.
Mekkes JR, de Vries HJ, Kammeyer A. Solar urticaria induced by infrared radiation. Clin Exp Dermatol. 2003;28:222–3.
Horio T. Solar urticaria-idiopathic? Photodermatol Photoimmunol Photomed. 2003;19(3):147–54.
Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42(2 pt 1):208–13.
Varughese N, Petrella T, Singer M, Carlson JA. Plasmacytoid (CD68+ CD123+) monocytes may play a crucial role in the pathogenesis of hydroa vacciniforme: a case report. Am J Dermatopathol. 2009;31:828–33.
Hirai Y, et al. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected gdT cells. J Invest Dermatol. 2012;132:1401–8.
Yap LM, Foley P, Crouch R, Baker C. Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology clinic. Australas J Dermatol. 2003;44:256–62.
Trakatelli M, et al. Photodermatoses with onset in the elderly. Br J Dermatol. 2009;161 Suppl 3:69–77.
Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther. 2003;16:45–51.
Honigsmann H. Mechanisms of phototherapy and photochemistry for photodermatoses. Dermatol Ther. 2003;16(1):23–7.
Chew A-L, et al. Contact and photocontact sensitization in chronic actinic dermatitis: a changing picture. Contact Dermatitis. 2010;62:42–6.
Wolverton JE, Soter NA, Cohen DE. The natural history of chronic actinic dermatitis: an analysis at a single institution in the United States. Dermatitis. 2014;25(1):27–31.
Tartar D, et al. Update on the immunological mechanism of action behind phototherapy. J Drugs Dermatol. 2014;13(5):564–8.
Weichenthal M, Schwarz T. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed. 2005;21(5):260–6.
Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA) The PUVA Follow-up Study. N Engl J Med. 1997;336(15):1041–5.
Breuer-McHam J, et al. Activation of HIV in human skin by ultraviolet B radiation and its inhibition by NFkB blocking agents. Photochem Photobiol. 2001;74:805–10.
McDonald H, Cruz PD. Phototherapy and HIV infection. In: Krutmann J, editor. Dermatological phototherapy and photodiagnostic methods. 2nd ed. Heidelberg: Springer; 2007.
Menon K, et al. Psoriasis in patients with HIV infection: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62:291–9.
Gambichler T, Terras S, Kreuter A. Treatment regimens, protocols, dosage and indications for UVA1 phototherapy: facts and controversies. Clin Dermatol. 2013;31:438–54.
Bulat V, et al. The mechanisms of action of phototherapy in the treatment of the most common photodermatoses. Coll Antropol. 2011;35 Suppl 2:147–51.
Dupont E, Craciun L. UV-induced immunosuppressive and anti-inflammatory actions: mechanisms and clinical applications. Immunotherapy. 2009;1(2):205–10.
Korbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14(5):329–34.
Erceg A, de Jong EMJG, van de Kerkhof PCM. The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. J Am Acad Dermatol. 2013;69:609–15.
Acknowledgement
We would like to thank the previous authors of this chapter, Christopher Hansen, Justin J. Leitenberger, and Heidi T. Jacobe, whose contributions established a strong foundation and formed the basis for the organization of this update.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Questions
Questions
-
1.
Which of the following wavelengths of light correctly describes the UVA1 spectrum?
-
A.
200–290 nm
-
B.
290–320 nm
-
C.
320–340 nm
-
D.
340–400 nm
-
E.
400–800 nm
-
A.
-
2.
Which of the following cytokines is critical to UV-induced immunosuppression?
-
A.
IL-1
-
B.
IL-5
-
C.
IL-10
-
D.
TGF-beta
-
E.
Interferon-alpha
-
A.
-
3.
Phototesting of patients with polymorphic light eruption is most likely to demonstrate which of the following findings?
-
A.
Decreased MED-A and decreased MED-B
-
B.
Decreased MED-A and normal MED-B
-
C.
Normal MED-A and decreased MED-B
-
D.
Normal MED-A and normal MED-B
-
E.
Vesiculation and scarring in response to UVA exposure
-
A.
-
4.
Patch test positivity to para-pheylenediamene (PPD) is most likely in patients with which of the following immunologically medicated photodermatoses?
-
A.
Actinic Prurigo
-
B.
Chronic Actinic Dermatitis
-
C.
Hydroa Vacciniforme
-
D.
Polymorphic Light Eruption
-
E.
Solar Urticaria
-
A.
-
5.
Which of the following presentations is characteristic of actinic prurigo?
-
A.
A 5 year old boy with itchy papules and excoriations on the face and neck, conjunctivitis, and cheilitis lasting throughout the year
-
B.
An 8 year old boy with recurrent vesicles on the cheeks that umbilicate and heal with pox-like scars
-
C.
A 10 year old boy with itchy papules on the ears for 1–2 weeks every spring
-
D.
A 24 year old woman with itchy papules on the forearms for 1–2 weeks every spring
-
E.
A 60 year old man with itchy lichenified plaques on the hands, face, and neck
-
A.
Answers
-
1.
D
-
2.
C
-
3.
D
-
4.
B
-
5.
A
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Turrentine, J.E., Cruz, P.D. (2017). Photoimmunology. In: Gaspari, A., Tyring, S., Kaplan, D. (eds) Clinical and Basic Immunodermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-29785-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-29785-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29783-5
Online ISBN: 978-3-319-29785-9
eBook Packages: MedicineMedicine (R0)